Given the following information, prepare a trial balance for Merck & Co., Inc. as of December 31, 2024:

Account	Debit ($)	Credit ($)
Cash	$260,000,000
Accounts Receivable	$265,000,000
Inventory	$240,000,000
Equipment	$960,000,000
Accumulated Depreciation		$450,000,000
Accounts Payable		$400,000,000
Notes Payable		$880,000,000
Common Stock		$1,050,000,000
Retained Earnings		$483,000,000
Sales Revenue		$1,150,000,000
Cost of Goods Sold	$575,000,000
Operating Expenses	$410,000,000